Key result
This editorial highlights the ongoing mysteries in hypertrophic cardiomyopathy, specifically the relationship between sudden cardiac death and coronary artery bridging.
Discusses the clinical relevance and potential relationship between coronary artery bridging and sudden cardiac death in hypertrophic cardiomyopathy.
Hypertrophic cardiomyopathy (HCM) is a heterogeneous disease at the clinical, phenotypic, and molecular level.1 In spite of considerable progress in understanding the disease, many issues continue to be shrouded in mystery, with very slow and often incomplete shedding of the veils, reminiscent of Salome’s dance. These issues include the unpredictable occurrence of sudden cardiac death, the clinical relevance of coronary artery bridging, and their possible relationship.
No takes yet. Share an insight, caveat, or question.
Olivotto et al. (2009) conducted an editorial in Hypertrophic cardiomyopathy (HCM). This editorial highlights the ongoing mysteries in hypertrophic cardiomyopathy, specifically the relationship between sudden cardiac death and coronary artery bridging.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: